Alessa Therapeutics ("Alessa"), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...
The Punch on MSN
Emergence of HIFU treatment for prostate cancer, tumours, a game-changer – Specialists
Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...
DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...
The American Cancer Society supported five bills aimed at cancer prevention and treatment in 2025, but only one passed.
Researchers have identified chromosomal instability in circulating tumour cells as a prognostic and predictive biomarker in ...
That wide-ranging impact is why Popular Science chose the drops as the 2025 Health category winner. This year’s list also ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
A Comprehensive OverviewThe global Peptide Cancer Vaccine Market is valued at USD 1.2 Billion in 2025 and is projected to reach a value of USD 15.72 Billion by 2035 at a CAGR (Compound Annual Growth ...
Jacksonville Journal-Courier on MSNOpinion
Commentary: When medical misinformation costs lives — Balancing free speech and public health
In my corner of the world, it feels like 2020 all over again, experiencing the push and pull between losing someone I love ...
Plans to seek regulatory approval to commence a Phase III trial in the US and Canada VANCOUVER, BC, Jan. 8, 2026 /PRNewswire/ -- Sustained Therapeutics Inc. ("Sustained Therapeutics" or the "Company") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback